Latest Targeted therapy Stories
DURHAM, N.C., April 16, 2015 /PRNewswire-iReach/ -- The majority of gastric cancers harbor genomic alterations (GAs) associated with potential benefit from targeted therapies, according to a
Debiopharm presents preclinical results for 2 anti-cancer targeted therapies Debio 1143 and Debio 1347 LAUSANNE, Switzerland, April 16, 2015 /PRNewswire/ -- Debiopharm International
Thomas Jefferson University, University of California at San Francisco, MD Anderson and University of Pennsylvania to present data on a liquid biopsy platform for genomic sequencing at AACR.
LONDON, April 8, 2015 /PRNewswire/ -- SummaryGBI Research, has released the pharma report -"Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline
Study Using Caris Molecular Intelligence's Multiplatform Profiling Service Highlighted in Plenary Session at Society of Surgical Oncology Symposium IRVING, Texas, March 27, 2015 /PRNewswire/
RnRMarketResearch.com adds HER-2 Positive Breast Cancer Market in the US 2015-2019 and Global HER-2 Positive Breast Cancer Market 2015-2019 industry research reports in its store. DALLAS, March
The use of combination targeted therapies will improve progression-free disease as well as survival rates, finds Frost & Sullivan LONDON, March 17, 2015 /PRNewswire/ -- Despite the availability
- On track to file IND for BLU-554 and initiate clinical studies by mid-2015 - CAMBRIDGE, Mass., March 16, 2015 /PRNewswire/ -- Blueprint Medicines today announced publication of the discovery
TAMPA, Fla., March 12, 2015 /PRNewswire/ -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc.
Close competition encourages established manufacturers to broaden the drug pipeline for targeted therapies, finds Frost & Sullivan LONDON, March 3, 2015 /PRNewswire/ -- Although lung
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).